Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimepinostat in Cushing Disease
NCT05971758Phase 2Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fimepinostat in Cushing's disease (CD), sponsored by University of California, Los Angeles. Started Jan 2025; status: recruiting.
02
Drugs
fimepinostat
03
Conditions
Cushing's disease (CD)
Beyond the preview
Go deeper on NCT05971758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05971758.